Company / Return on Assets (ROA)
Seres Therapeutics, Inc. Return on Assets (ROA) History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-82.3%
FY2025
5-year range
-82.3% / -18.8%
FY2021-FY2025
Trend
-337.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed -338% YoY in FY2025, a notable deviation from the 9-year average annual change of -99%.
Based on SEC 10-K filings.
-82.3% in FY2025 with a 10-year CAGR of -79.5%.
Declined from -25.6% to -82.3% over the past 3 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -56.7pp
- 5-Year Change
- -53.4pp
- 10-Year Change
- -79.5pp
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 337.7% year-over-year.
- Peak return on assets (roa) was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.18 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -82.3% | -337.7% |
| FY2023 | -18.8% | +26.4% |
| FY2022 | -25.6% | -29.0% |
| FY2021 | -19.8% | +31.4% |
| FY2020 | -28.8% | +57.3% |
| FY2019 | -67.5% | +11.2% |
| FY2018 | -76.0% | -163.0% |
| FY2017 | -28.9% | -371.5% |
| FY2016 | -6.1% | -118.1% |
| FY2015 | -2.8% | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 24, 2026